Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis.

The study demonstrates the importance of systemic genetics in identifying potential drug- targeted therapies for NSCLC. The integrative system- level approach should contribute to a better understanding of disease etiology and may accelerate drug discovery for many cancer types.